The store will not work correctly when cookies are disabled.
Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.
Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.